Month: March 2023

Brian Pratt Also Joins Board, Replacing Director Dane Derbyshire LATHAM, N.Y., March 31, 2023 (GLOBE NEWSWIRE) — Latham Group, Inc. (“Latham” or “the Company”), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced the appointment of DeLu Jackson, currently Executive Vice President and Chief Marketing Officer of ADT Inc., to Latham’s Board of Directors (the “Board”). In addition, Latham’s Board has appointed Brian Pratt, Vice President at Pamplona Capital Management, to serve as a director, replacing Dane Derbyshire, who has stepped down from the Board in connection with his departure from Pamplona Capital Management. Since 2019, Mr. Pratt has worked closely with the Board and Latham management on financial, operational,...

Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, March 31, 2023 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the year ended December 31, 2022 and provided an update on recent corporate developments. “We entered 2023 from a position of strength and will continue to build on the momentum generated last year to advance our important clinical programs in hard-to-treat cancers,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings. “We see continued enthusiasm from clinical investigators and patients alike and hope to make even more progress toward completing these key studies....

CENTREVILLE, Va., March 31, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was selected by the United States Army Corps of Engineers (USACE) Norfolk District to deliver a new Explosive Decomposition Chamber (EDC) facility at Holston Army Ammunition Plant (HSAAP) in Kingsport, Tennessee. The four-year, $164 million contract is new work for the firm. “Our team is uniquely equipped to deliver solutions for the most complex environmental challenges that our clients face,” said Jon Moretta, president, Engineered Systems, for Parsons. “This new facility will meet the Army’s mission of reducing environmental impacts by transitioning from the open burning explosive waste treatment process to a technology-driven closed destruction solution. We look forward to leveraging our technical design, engineering,...

Please find enclosed Eika Boligkreditt AS’ annual report for 2022.AttachmentAnnual report 2022 – Eika Boligkreditt AS

Today, Wereldhave, the Municipality of Dordrecht, tenants and partners in development celebrated the official opening of the completely renewed Full Service Center Sterrenburg. The official opening act was performed by alderwoman Tanja de Jonge of the Municipality of Dordrecht, Chief Commercial Officer Pieter Polman of Wereldhave and local entrepreneur Jan-Willem Leemhuis of Jumbo Foodmarket. During the celebrations, the parties involved looked back on the high ambition level of the project, their successful collaboration and the clearly visible end-result. Sterrenburg marks the fifth completed Full Service Center by Wereldhave, after Presikhaaf and City-Center Tilburg in the Netherlands and Les Bastions and Ring Kortrijk in Belgium. The project was delivered on time and within budget. Full Service Center Sterrenburg opens almost fully...

VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global healthcare technology company developing innovative Virtual Care solutions for the multibillion-dollar Healthcare market, has signed 10 new contracts in the United States. These new contracts, with eight physician practices in Nevada and Northern California, and two home health agencies in Texas, are expected to add more than 5,000 new patients to Reliq’s iUGO Care platform by the end of 2023 and generate an average revenue of US$65 monthly per patient at an expected 75% gross margin. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional...

Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154, and 232 days Strong graft function observed in all three participants with mean eGFRs above 70 mL/min/1.73m2 at measured timepoints Data from 16 participants in the Phase 2 IgAN study demonstrated tegoprubart to be safe and well tolerated, with no serious or severe adverse events reported IRVINE, Calif., March 31, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today reported results from the Company’s ongoing Phase 1b open-label trial evaluating tegoprubart in patients undergoing kidney transplantation at the World Congress of Nephrology, which is taking place March 30 to April 2, 2023. In addition, Eledon reported safety data from the Company’s Phase 2a trial of tegoprubart in IgA Nephropathy (IgAN). The...

Rye Brook, New York, March 31, 2023 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. II (NASDAQ: SAMA) (the “Company”) today announced further actions being undertaken in anticipation of the previously announced special meeting in lieu of the 2023 annual meeting of stockholders of the Company to be held at 12:00 p.m. Eastern Time on April 4, 2023 (the “Special Meeting”) for the sole purpose of considering and voting on, among other proposals, a proposal to extend the date by which the Company must consummate an initial business combination (the “Extension”) from April 13, 2023 to October 13, 2023 or such earlier date as determined by the Company’s board of directors (the “Charter Amendment Proposal”). Class B Shares to Be Converted if Extension is Implemented If the Charter Amendment Proposal is approved at the Special...